News Briefs BDC Capital, DSM Venturing lead Series B funding of Interface Biologics brad meikle - 13 January 2015 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
